The largest database of trusted experimental protocols
> Physiology > Organism Attribute > Body Height

Body Height

Body Height is a key metric that reflects an individual's overall physical development and growth.
It is influenced by a complex interplay of genetic, environmental, and nutritional factors.
Researchers studying body height can utilize PubCompare.ai's AI-driven protocol comparison tool to streamline their research process.
This powerful platform allows users to easily locate relevant protocols from literature, pre-prints, and patents, and leverages AI to identify the best protocols and products for their specific needs.
By optimizing their body height research with PubCompare.ai, researchers can unlock new insights and accelerate their discoveries.
PubCompare.ai's intuitive interface and cutting-edge AI capabilities make it an invaluable resource for any researcher interested in exploring the factors that contribute to human height.

Most cited protocols related to «Body Height»

Besides a clinical and laboratory evaluation, each subject underwent a liver ultrasonography, an anthropometric assessment and a 7-day diary of food intake (7DD) [1 (link)]. HBsAg and anti-HCV antibodies were assessed and subjects with anti-HCV antibodies underwent an HCV-RNA assessment to confirm HCV infection [1 (link),14 (link)]. ALT, aspartate transaminase (AST), GGT, glucose, triglycerides and cholesterol were measured by standard laboratory methods after 8-hr fasting. Insulin was measured by radio-immuno-assay (ADVIA Insulin Ready Pack 100, Bayer Diagnostics, Milan, Italy), with intra- and inter-assay coefficients of variation < 5%. FL was diagnosed by the same operator at ultrasonography [6 (link)]. Weight, stature, circumferences (waist and hip) and skinfolds (triceps, biceps, subscapular and suprailiac) were measured by two trained dietitians who had been standardized before and during the study according to standard procedures [15 ]. Body mass index (BMI) was calculated as weight (kg)/stature (m)2 and the sum of 4 skinfolds by summing triceps, biceps, subscapular and suprailiac skinfolds [16 (link),17 (link)]. The 7DD was administered to the subjects by two trained dietitians, who discussed it with the subject when she/he returned it one week later [18 (link)]. To avoid the confounding effect of seasonality on food intake, the 7DD diary was administered to a similar number of patients with and without SLD each month [19 ]. Mean daily ethanol intake was calculated as the mean value of ethanol intake as assessed by the 7DD [20 ]. The study protocol was approved and supervised by the Scientific Committee of the Fondo per lo Studio delle Malattie del Fegato (Trieste, Italy), and all subjects gave their written informed consent to participate.
Full text: Click here
Publication 2006
Aspartate Transaminase Biological Assay Body Height Cholesterol Dietitian Eating Ethanol Glucose Hepatitis B Surface Antigens Hepatitis C Hepatitis C Antibodies Index, Body Mass Insulin Liver Patients Radioimmunoassay Triglycerides Ultrasonography
Anthropometric measurement of each subject was performed by trained nurses in the morning after fasting for at least 8 h. Body height was recorded to the nearest 0.5 cm and body weight to the nearest 0.1 kg. BMI was defined as body weight (kilograms) divided by the square of body height (meters). WC-IC was measured in the horizontal plane at the superior border of the right iliac crest. WC-mid was measured in the horizontal plane midway between lowest rib and the iliac crest. Both WC-IC and WC-mid were measured to the nearest 0.1 cm at the end of a normal expiration. Before recording the measurement, the nurse would ensure that the tape was snug but did not compress the skin and was parallel to the floor. The reproducibility was assessed. WC-IC and WC-mid were measured repeatedly in 10 men and 10 women by 3 trained nurses on 3 consecutive days. The coefficients of variation for WC-IC were 0.8% (range 0.5–1.7%) for women and 0.6% (range 0.3–1.4%) for men. The coefficients of variation for WC-mid were 0.4% (range 0–0.7%) for men and 0.9% (range 0.5–1.9%) for women.
Publication 2013
Body Height Body Weight Iliac Crest Nurses Skin Woman
The KIDMED questionnairewas used to evaluate the adherence to a Mediterranean diet in adolescents. It consists of 16 items, where there are 4 questions denoting a negative connotation to the Mediterranean diet (consumption of fast food, baked goods, sweets, and skipping breakfast) and 12 questions denoting a positive connonation (consumption of oil, fish, fruits, vegetables, cereals, nuts, pulses, pasta or rice, dairy products, and yoghurt). Questions denoting negative connotation are scored with −1, while positive connotation questions are scored with +1. According to the KIDMED index, a score of 0–3 reflects poor adherence to the Mediterranean diet, a score of 4–7 describes average adherence, and a score of 8–12 good adherence [14 (link)]. The same questionnaire has been previously used in the college student population [26 (link),27 (link)]. Additional variables were body height, weight, and calculated body-mass index by using a formula: weight (kg)/height (m2). Additionally, we asked about educational level of both parents and categorized it into fivecategories: (1) primary school, (2) secondary school, (3) faculty (bachelor degree), (4) faculty (master’s degree), and (5) faculty (PhD).
Full text: Click here
Publication 2017
Adolescent Body Height Cereals Dairy Products Diet, Mediterranean Faculty Fast Foods Fishes Fruit Index, Body Mass Nuts Oryza sativa Parent Pastes Pulses Student Vegetables Yogurt
Basic demographic (age, gender) and anthropometric (body weight and stature) data were obtained first. Thereafter, measures of endurance, dexterity, and strength were obtained. Among the strength measures were the FRSTST and isometric knee extension strength, which were measured in varying order.
The FRSTST required participants to stand up from and sit down on a slightly padded 43 cm high armless chair (Fig. 1) as quickly as possible 5 times. Participants folded their arms across their chests and were instructed to stand-up completely and make firm contact when sitting. Timing began on the command “go” and ceased when the participants sat after the fifth stand-up. Participants were allowed a practice trial of 2 repetitions before the timing of 2 test trials of 5 repetitions. The fastest of the 2 test trials was used in subsequent analysis.
Isometric knee extension strength was determined using 2 different procedures; a MicroFET hand-held dynamometer was used to measure knee extension force (Fig. 2) whereas a Biodex isokinetic dynamometer was used to measure knee extension torque. For both procedures participants sat with stabilization provided by straps, with their knees at about 90 degrees of flexion, and with the dynamometer input pads positioned just proximal to the malleoli. Both procedures involved 3 trials with each lower limb. The first trial was submaximal and served as practice. The following 2 test trials were at maximal effort. Regardless, participants were requested to come to the requested effort over a second or 2 and to continue making such effort until requested to stop (ie, after a total of 5 seconds). For each procedure, the greatest of the 2 test trials of each side was used in subsequent analysis.
Publication 2010
ARID1A protein, human Arm, Upper Body Height Body Weight Chest Gender Knee Lower Extremity Neoplasm Metastasis Torque
All participants completed a uniform questionnaire detailing history of diabetes, medication use, smoking status, and alcohol consumption. Body height and weight were measured without shoes and outer clothing. BMI was calculated according to weight in kilograms divided by square of height in meters. Waist circumference was measured using a soft tape at midway between the lowest rib and iliac crest in standing position. All blood samples were obtained after at least 12 h of fasting. Serum total cholesterol, HDL-cholesterol, triglyceride(TG) were measured using oxidase method32 (link). LDL cholesterol was calculated using the Friedewald equation. Liver enzymes (ALT, AST) were measured by Ultraviolet (UV) lactate and malate dehydrogenase methods on a model 7600 automated bio-analyser (Hitachi, Tokyo, Japan). Plasma glucose concentrations were measured using glucose oxidase method. Serum insulin concentrations were determined using an electrochemiluminescence immunoassay33 (link).
Full text: Click here
Publication 2016
BLOOD Body Height Cholesterol Cholesterol, beta-Lipoprotein Diabetes Mellitus Enzymes Glucose High Density Lipoprotein Cholesterol Iliac Crest Insulin Lactates Liver Malate Dehydrogenase Oxidase, Glucose Oxidases Pharmaceutical Preparations Plasma Serum Triglycerides Waist Circumference

Most recents protocols related to «Body Height»

Not available on PMC !

Example 1

Subsequently, a modification example 1 of the fourth embodiment will be described with reference to FIG. 26. FIG. 26 is a cross-sectional view of FIG. 24.

As illustrated in FIG. 26, a bonding wire that transfers the voltage VSS may be arranged so as to be in contact with the memory chip 100 provided in the upper layer in the Z direction or the spacer 600 (refer to C in the drawing). Since the voltage VSS is a low voltage in the circuit, even if it is in contact with the other memory chip 100 or the spacer 600, the influence thereof is small.

According to this, the film thickness dS of the spacer 600 can be reduced, and the height of the stacked body of the memory chips 100 in the Z direction can be reduced.

Full text: Click here
Patent 2024
Body Height DNA Chips Medical Devices Memory
A case report form was developed to record general characteristics, clinical diagnosis, and biochemical examination. Waist circumference (WC) was measured at the middle point between the costal margin and iliac crest. BMI was calculated as body weight in kilograms divided by body height in meters squared (kg/m2). Smoking habit was categorized as current smoking, ever smoking, or no smoking. Current smoking was determined when subjects were smoking currently and more than one cigarette daily in at least one year continuously. Ever smoking was determined when subjects smoked more than one cigarette daily, but had quitted smoking at least one year before. Drinking habit was categorized as current drinking, ever drinking, or no drinking. Current drinking was determined when subjects were drinking liquor, beer or wine currently in at least one year. Ever drinking was determined when subjects drank previously, but had quitted drinking at least one year before. History of lipid disorders included that plasma total cholesterol was ≥ 5.7 mmol/l, or low-density lipoprotein cholesterol (LDL-C) was ≥ 3.6 mmol/l, or high-density lipoprotein cholesterol (HDL-C) < 1.04 mmol/l, triglyceride was ≥ 1.7 mmol/l, or treatment with antihyperlipidemic agents due to hyperlipidemia. Hypertension was diagnosed by systolic blood pressure (SBP) ≥ 140 mmHg, or diastolic blood pressure (DBP) ≥ 90 mmHg, or being actively treated with anti-hypertension drugs. Diabetes mellitus was diagnosed by a fasting plasma glucose ≥ 7.0 mmol/l, or by a random plasma glucose ≥ 11.1 mmol/l, or when they were actively receiving therapy using insulin or oral medications for diabetes. Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2.
Full text: Click here
Publication 2023
Amniotic Fluid Antihypertensive Agents Beer Body Height Body Weight Cholesterol Cholesterol, beta-Lipoprotein Chronic Kidney Diseases Costal Arch Diabetes Mellitus Glomerular Filtration Rate Glucose High Blood Pressures High Density Lipoprotein Cholesterol Hyperlipidemia Hypolipidemic Agents Iliac Crest Insulin Lipid Metabolism Disorders Pharmaceutical Preparations Plasma Pressure, Diastolic Systolic Pressure Therapeutics Triglycerides Waist Circumference Wine
The participants’ characteristics and anthropometric indices, including age, sex, body weight, height, body mass index (BMI), and blood pressure, were obtained. BMI was calculated as body weight (kg) divided by body height (m2). Blood was sampled for laboratory assays after the patients had fasted for ten to 12 h overnight. Fasting blood glucose and serum lipids were measured using Abbott—Architect Plus, a clinical chemistry autoanalyzer (Abbott, Abbott Park, IL, United States). Glycated hemoglobin (HbA1c) determination was performed using D-100®, a high-performance liquid chromatography analyzer (Bio-Rad Laboratories, Hercules, CA, United States).
Full text: Click here
Publication 2023
Biological Assay BLOOD Blood Glucose Blood Pressure Body Height Body Weight Hemoglobin, Glycosylated High-Performance Liquid Chromatographies Index, Body Mass Lipids Patients Serum
The participant timeline is summarized in Table 3. Candidates who consent to participate will be checked for eligibility based on the inclusion/exclusion criteria, and enrollment will be completed after confirmation of participant eligibility. Physical examination, Eastern Cooperative Oncology Group performance status (PS), body weight, body height, complete blood count (CBC), serum biochemistry, activated partial prothrombin time, prothrombin time-international normalized ratio, thyroid stimulating hormone, free T4, and urine analyses are performed within 14 days before registration. Echocardiography, electrocardiography, contrast-enhanced computed tomography (CT) of the chest, abdomen, and pelvis, and additional CT/magnetic resonance imaging (MRI) of the lesions will be performed within 28 days before registration. Plain CT is acceptable when contrast agents cannot be administered due to allergies, asthma, etc.

The study schedule

#Echocardiography is performed in Arm C if any cardiac-related symptoms are observed.§ECG will be performed on Day 28 of Arm C and every 8
weeks thereafter.*Enhanced CT of chest-abdomen-pelvis, and additional CT/MRI of the lesions to determine efficacy will be performed every 4 weeks on the first four occasions after initiation of protocol treatment, and every 6 weeks thereafter

Participants will commence the treatment protocol within 14 days of registration. The treatment protocol is continued until one of the following termination criteria are met: (1) exacerbation of disease (judged as ineffective treatment); (2) the treatment protocol cannot be continued due to adverse events including grade 4 non-hematologic toxicity and delay of 56 days before the start of the next course; (3) the patient requests termination of treatment for reasons related to adverse events; (4) the patient requests termination of treatment for reasons unrelated to adverse events; (5) death during treatment; and (6) post-enrollment exacerbation prior to the initiation of treatment (inability to start the treatment protocol due to rapid progression), discovery of protocol violation, change of treatment due to a change in the pathological diagnosis after enrollment, or other reasons that make the patient ineligible for treatment.
Treatment efficacy will be determined by performing contrast-enhanced chest-abdomen-pelvis CT and additional CT/MRI of the lesions every 4 weeks on the first four occasions after initiation of the treatment protocol, and every 6 weeks thereafter. After termination of the treatment protocol, physical examination, PS, body weight, CBC, serum biochemistry, and adverse events will be assessed every 6 months. If treatment is terminated for reasons other than progression of the disease, 6-weekly CT examination will be continued until disease progression.
Full text: Click here
Publication 2023
Abdomen Asthma Body Height Body Weight Chest Diagnosis Disease Progression Echocardiography Eligibility Determination Heart Hypersensitivity International Normalized Ratio Neoplasms Patients Pelvis Physical Examination Serum Thyrotropin TimeLine Times, Prothrombin Treatment Protocols Urinalysis X-Ray Computed Tomography
Echocardiography was performed by trained sonographers at our hospital using a Philips iE33 Doppler echocardiography system with a real-time 3D probe X3-1 (frequency 1–3 MHz) (Philips, Best, The Netherlands). Left ventricular end-diastolic diameter (LVDd), septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), and ejection fraction (EF) were measured. All the above data were averaged over three cardiac cycles.
Left ventricular mass (LVM) was estimated by the formula of Devereux et al.: LVM (g) = 0.8 × 1.04 [(LVID + IVS + PWT)3 − (LVIDd)3] + 0.6.LVM was normalized for body height to the 2.7 (LVMI). LVH was defined as LVMI > 46.7 g/m2.7 in women and LVMI > 49.2 g/m2.7 in men [46 (link)].
Cardiac parameter, Relative wall thickness (RWT), was calculated as the ratio of twice the posterior wall thickness divided by the left ventricular internal diameter in diastole, and a value over 0.42 cm was defined as an elevated RWT [47 (link)].Four categories of left ventricular geometry were defined: (1) normal (normal RWT and LVMI); (2) eccentric hypertrophy (normal RWT and high LVMI); (3) concentric hypertrophy (high RWT and high LVMI); and (4) concentric remodeling (high RWT and normal LVMI).
Full text: Click here
Publication 2023
Body Height Diastole Echocardiography Heart Hypertrophy Left Ventricles Multiple Endocrine Neoplasia Type 2a Woman

Top products related to «Body Height»

Sourced in Germany, United Kingdom, United States, Japan, Jamaica, Switzerland, Brazil
A stadiometer is a medical device used to measure a person's height. It consists of a vertical scale, typically marked in centimeters or inches, with a horizontal headpiece that can be lowered to rest on top of the person's head, allowing for an accurate measurement of their stature.
Sourced in United Kingdom, Germany, United States
The Stadiometer is a medical device used to measure an individual's height. It consists of a vertical ruler or scale mounted on a stable base, with a sliding horizontal headpiece that is lowered onto the top of the person's head to record their height.
Sourced in United Kingdom, Germany
The Harpenden stadiometer is a precision instrument used to measure the height of individuals. It is a mechanical device designed to accurately record an individual's standing height.
Sourced in Japan, United Kingdom, Germany, United States, Netherlands
The BC-418MA is a body composition analyzer that measures body weight, body fat percentage, and other body composition parameters. It uses bioelectrical impedance analysis (BIA) technology to provide detailed information about an individual's body composition.
Sourced in United Kingdom, Germany
The Leicester Height Measure is a medical device used to accurately measure an individual's height. It consists of a vertical measuring scale attached to a stable base, allowing for precise height measurements. The device is designed to provide reliable and consistent height data for clinical and research purposes.
Sourced in Germany, United Kingdom, Japan, United States
The Seca 213 is a portable stadiometer designed for measuring the standing height of individuals. It features a sliding headpiece that can be positioned on the top of the head, and a measuring scale that allows for precise height measurements. The stadiometer is constructed with durable materials and is easy to set up and use.
Sourced in Japan, United Kingdom, Germany, United States
The Tanita BC-420MA is a body composition analyzer that measures body weight, body fat percentage, and other body composition metrics. It provides accurate and reliable measurements through the use of bioelectrical impedance analysis technology.
Sourced in Germany, United Kingdom, United States, China, France, Switzerland
A digital scale is a weighing device that measures the mass or weight of an object using electronic sensors. It provides a precise and digital display of the measured value.
Sourced in United States, United Kingdom, Italy, Belgium, Germany
The Lunar Prodigy Advance is a dual-energy X-ray absorptiometry (DXA) system designed for bone mineral density (BMD) assessment. It utilizes low-dose X-rays to measure the bone density of the spine, hip, and other skeletal sites. The system provides precise and reproducible measurements to aid in the diagnosis and management of osteoporosis and other bone-related conditions.
Sourced in United Kingdom
The Skinfold Caliper is a device used to measure the thickness of a fold of skin and underlying fat tissue. It provides an estimate of body composition by assessing subcutaneous fat.

More about "Body Height"

Body Height, also known as Stature, is a crucial metric that reflects an individual's overall physical development and growth.
It is influenced by a complex interplay of genetic, environmental, and nutritional factors.
Researchers studying this anthropometric measure can utilize various tools and techniques, such as the Stadiometer, Harpenden stadiometer, BC-418MA, Leicester Height Measure, Seca 213 stadiometer, BC-420MA, Digital scale, and Lunar Prodigy Advance, to accurately measure and analyze body height.
The Stadiometer is a widely used instrument for measuring height, while the Harpenden stadiometer is a specialized device that provides more precise measurements.
The BC-418MA and BC-420MA are bioelectrical impedance analysis (BIA) devices that can measure not only height but also other body composition metrics like weight, body fat percentage, and muscle mass.
The Leicester Height Measure and Seca 213 stadiometer are other popular height measurement tools that offer accurate and reliable results.
Researchers may also utilize Skinfold calipers to assess body composition and gain a more comprehensive understanding of an individual's physical development.
By optimizing their body height research with PubCompare.ai's AI-driven protocol comparison tool, researchers can streamline their research process, unlock new insights, and accelerate their discoveries.
This powerful platform allows users to easily locate relevant protocols from literature, pre-prints, and patents, and leverages AI to identify the best protocols and products for their specific needs.
With PubCompare.ai's intuitive interface and cutting-edge AI capabilities, researchers can explore the factors that contribute to human height more efficiently and effectively.